NCT00346190

The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.

A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 10 (planned)
• Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
• Sex: All
• Age: 55 Years
• Healthy volunteers: Not accepted

Summary

To determine whether administration of Alendronate early is more effective than late in the prevention of osteoporosis following a hip fracture

Conditions

• Osteoporosis

Interventions

Type	Name	Description
DRUG	Alendronate

Timeline

• Start date: 2003-01-01
• Completion: 2007-04-01
• First posted: 2006-06-29
• Last updated: 2007-04-12

Locations

1 site across 1 country: Canada